Anuh Pharma Limited — Board Meeting, 24-05-2025: Outcome of Board Meeting

Anuh Pharma has announced a board meeting that approved the financial results for the quarter and half-year, reporting a consolidated PAT of ₹47.35 Cr on revenues of ₹671 Cr. The Board proposed a 1:1 bonus share issue, doubling the equity base pending shareholder approval, along with a final dividend of ₹1.50 per post-bonus share (30% of face value). Leadership updates include the re-appointment of Joint MDs Ritesh Bipin Shah and Vivek Bipin Shah for five years starting January 2026. Auditors for internal, secretarial, and cost areas were also re-appointed.